BTG agrees to obtain PneumRx for $475 million PneumRx.

BTG agrees to obtain PneumRx for $475 million PneumRx, Inc delayed ejaculation . in a deal value up to $475 million, predicated on an initial account of $230 million or more to $245 million in performance-related milestone payments. Located in London, BTG can be an international specialist health care company that is dynamic in interventional specialty and medication pharmaceuticals. Their current interventional portfolio contains site particular treatments for severe bloodstream clots including pulmonary embolisms, liver tumors, and varicose veins.